SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-084737
Filing Date
2023-11-08
Accepted
2023-11-08 16:05:26
Documents
47
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_relmadatherap.htm   iXBRL 10-Q 466486
2 CERTIFICATION f10q0923ex31-1_relmada.htm EX-31.1 10038
3 CERTIFICATION f10q0923ex31-2_relmada.htm EX-31.2 10035
4 CERTIFICATION f10q0923ex32-1_relmada.htm EX-32.1 4179
5 CERTIFICATION f10q0923ex32-2_relmada.htm EX-32.2 4368
  Complete submission text file 0001213900-23-084737.txt   2906445

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rlmd-20230930.xsd EX-101.SCH 31820
7 XBRL CALCULATION FILE rlmd-20230930_cal.xml EX-101.CAL 21242
8 XBRL DEFINITION FILE rlmd-20230930_def.xml EX-101.DEF 151643
9 XBRL LABEL FILE rlmd-20230930_lab.xml EX-101.LAB 319907
10 XBRL PRESENTATION FILE rlmd-20230930_pre.xml EX-101.PRE 162841
41 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_relmadatherap_htm.xml XML 253139
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39082 | Film No.: 231387758
SIC: 2834 Pharmaceutical Preparations